AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 161 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $474,000 | +182.1% | 28,349 | +143.9% | 0.00% | – |
| Q1 2020 | $168,000 | -82.0% | 11,622 | -58.3% | 0.00% | -100.0% |
| Q4 2019 | $932,000 | +73.9% | 27,859 | +8.9% | 0.00% | 0.0% |
| Q3 2019 | $536,000 | -38.0% | 25,585 | -38.4% | 0.00% | 0.0% |
| Q2 2019 | $865,000 | -28.3% | 41,565 | -23.0% | 0.00% | -50.0% |
| Q1 2019 | $1,206,000 | +8.7% | 53,964 | +16.3% | 0.00% | 0.0% |
| Q4 2018 | $1,109,000 | -20.8% | 46,383 | -9.7% | 0.00% | 0.0% |
| Q3 2018 | $1,401,000 | -3.7% | 51,342 | -5.1% | 0.00% | 0.0% |
| Q2 2018 | $1,455,000 | -5.8% | 54,108 | +11.6% | 0.00% | -33.3% |
| Q1 2018 | $1,544,000 | +65.0% | 48,496 | +96.0% | 0.00% | +50.0% |
| Q4 2017 | $936,000 | +63.6% | 24,737 | +7.2% | 0.00% | +100.0% |
| Q3 2017 | $572,000 | +20.9% | 23,068 | +0.2% | 0.00% | 0.0% |
| Q2 2017 | $473,000 | +20.7% | 23,017 | +27.6% | 0.00% | 0.0% |
| Q1 2017 | $392,000 | +11.0% | 18,035 | +4.5% | 0.00% | 0.0% |
| Q4 2016 | $353,000 | +37.4% | 17,260 | +0.7% | 0.00% | 0.0% |
| Q3 2016 | $257,000 | +93.2% | 17,134 | +39.4% | 0.00% | – |
| Q2 2016 | $133,000 | -20.8% | 12,291 | -0.5% | 0.00% | -100.0% |
| Q1 2016 | $168,000 | – | 12,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |